Search Results

You are looking at 161 - 170 of 4,064 items for :

  • Refine by Access: All x
Clear All
Full access

Worry About Daily Financial Needs and Food Insecurity Among Cancer Survivors in the United States

Zhiyuan Zheng, Ahmedin Jemal, Reginald Tucker-Seeley, Matthew P. Banegas, Xuesong Han, Ashish Rai, Jingxuan Zhao, and K. Robin Yabroff

Background The costs of medical care after a cancer diagnosis impose substantial financial hardship on cancer survivors and their families in the United States. 1 , 2 Studies have shown that cancer survivors have higher medical expenses, 3 , 4

Full access

Do Outcomes in Elective Colon and Rectal Cancer Surgery Differ by Weekday? An Observational Study Using Data From the Dutch ColoRectal Audit

Daniëlle D. Huijts, Onno R. Guicherit, Jan Willem T. Dekker, Julia T. van Groningen, Leti van Bodegom-Vos, Esther Bastiaannet, Johannes A. Govaert, Michel W. Wouters, and Perla J. Marang-van de Mheen

Background Although surgery has a crucial role in colorectal cancer (CRC) treatment, it is associated with considerable risks of postoperative complications and mortality 1 , 2 and a resultant increase in healthcare costs. 3 Severe complications

Full access

Lung Cancer Screening

Douglas E. Wood, George A. Eapen, David S. Ettinger, Lifang Hou, David Jackman, Ella Kazerooni, Donald Klippenstein, Rudy P. Lackner, Lorriana Leard, Ann N. C. Leung, Pierre P. Massion, Bryan F. Meyers, Reginald F. Munden, Gregory A. Otterson, Kimberly Peairs, Sudhakar Pipavath, Christie Pratt-Pozo, Chakravarthy Reddy, Mary E. Reid, Arnold J. Rotter, Matthew B. Schabath, Lecia V. Sequist, Betty C. Tong, William D. Travis, Michael Unger, and Stephen C. Yang

Lung cancer is the leading cause of cancer-related mortality in the United States and worldwide. 1 – 4 In 2011, it is estimated that 156,900 deaths (85,600 in men, 71,300 in women) from lung cancer will occur in the United States. 4 Five

Full access

Small Cell Lung Cancer

UCSF Helen Diller Family Comprehensive Cancer Center

Small cell lung cancer (SCLC) accounts for 15% of lung cancers. Nearly all cases of SCLC are attributable to cigarette smoking, and the remaining cases are presumably caused by environmental or genetic factors. Compared with non-small cell lung cancer, SCLC generally has a more rapid doubling time, a higher growth fraction, and earlier development of widespread metastases. SCLC is highly sensitive to initial chemotherapy and radiotherapy, but most patients eventually die from recurrent disease. These guidelines detail the management of SCLC from initial diagnosis and staging through treatment, and include information on supportive and palliative care. Important updates to the 2008 version include refined categories for performance status and the addition of topotecan as an option for patients who experience relapse.

For the most recent version of the guidelines, please visit

Full access

Paid Sick Leave Among Working Cancer Survivors and Its Associations With Use of Preventive Services in the United States

Zhiyuan Zheng, Stacey A. Fedewa, Farhad Islami, Leticia Nogueira, Xuesong Han, Jingxuan Zhao, Weishan Song, Ahmedin Jemal, and K. Robin Yabroff

Background Approximately 33% of cancer survivors are in their prime working age range, between 20 and 64 years. 1 A cancer diagnosis can alter employment trajectories and cause long-term productivity losses. 2 Previous research showed that

Full access

Chronic Pain Management in Cancer Survivors

Natalie Moryl, Nessa Coyle, Samuel Essandoh, and Paul Glare

U nfortunately, some cancer survivors with chronic cancer-related pain meet significant barriers limiting their access to medications previously determined effective and well-tolerated. An unintended consequence is pain that had been well

Full access

Population-Based Study on Cancer Subtypes, Guideline-Concordant Adjuvant Therapy, and Survival Among Women With Stage I–III Breast Cancer

Mei-Chin Hsieh, Lu Zhang, Xiao-Cheng Wu, Mary B. Davidson, Michelle Loch, and Vivien W. Chen

Background Since the molecular phenotypes of breast carcinomas were distinguished by gene expression patterns in 2000, breast cancer is no longer considered a single disease but rather a group of molecularly distinct neoplastic disorders. 1 – 4

Full access

Association of Chronic Immune-Mediated Diarrhea and Colitis With Favorable Cancer Response

Fangwen Zou, Hamzah Abu-Sbeih, Weijie Ma, Yuanzun Peng, Wei Qiao, Jianbo Wang, Amishi Y. Shah, Isabella C. Glitza Oliva, Sarina A. Piha-Paul, John A. Thompson, Hao Chi Zhang, Anusha S. Thomas, and Yinghong Wang

Background Immune checkpoint inhibitor (ICI) therapy significantly improves cancer outcomes by targeting CLTA-4 or PD-1/L1 and boosting T-cell–mediated immune responses and antitumor effects. 1 , 2 ICIs are widely used as first-line therapy

Full access

Prostate Biopsy Strategies: Current State of the Art

Badar M. Mian

The author has no financial interests, arrangement, or affiliations with the manufacturers of any products discussed in the article or with their competitors. References 1 Jemal A Murray T Samuels A . Cancer statistics, 2003

Full access

New Issues in Systemic Therapy for Ovarian Cancer

Deborah K. Armstrong

Most patients with ovarian cancer are diagnosed with advanced-stage cancer. Debulking surgery followed by chemotherapy is recommended. The standard front-line regimen is 6 cycles of paclitaxel plus carboplatin, with docetaxel a reasonable